注册 | 登录 | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

jyuh's Yamagishi [19 articles]

当前文献位于 jyuh's 文献库中 作者 Yamagishi. 你也可以 see everyone's Yamagishi.
  • Pericyte biology and diseases.
    International journal of tissue reactions, Vol. 27, No. 3. (2005), pp. 125-135.
    by S Yamagishi, T Imaizumi
    posted to no-tag by jyuh on 2008-04-22 10:53:42 as **
  • Troglitazone improves endothelial function and augments renal klotho mRNA expression in Otsuka Long-Evans Tokushima Fatty (OLETF) rats with multiple atherogenic risk factors.
    Hypertens Res, Vol. 24, No. 6. (November 2001), pp. 705-709.
    by T Yamagishi, Y Saito, T Nakamura, S Takeda, H Kanai, H Sumino, M Kuro-o, Y Nabeshima, M Kurabayashi, R Nagai
    posted to no-tag by jyuh on 2008-01-28 04:04:04 as **
  • Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney disease (Review Article)
    Nephrology, Vol. 12, No. 6. (December 2007), pp. 582-590.
    by Seiji Ueda, Sho-Ichi Yamagishi, Yusuke Kaida, Seiya Okuda
    posted to cv ckd adma by jyuh on 2008-01-20 04:22:02 as **
  • Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.
    Microvasc Res, Vol. 75, No. 1. (January 2008), pp. 130-134.
    by S Yamagishi, T Matsui, K Nakamura, H Inoue, M Takeuchi, S Ueda, K Fukami, S Okuda, T Imaizumi
    posted to no-tag by jyuh on 2008-01-16 02:07:30 as **
  • Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.
    J Mol Cell Cardiol, Vol. 43, No. 4. (October 2007), pp. 455-464.
    by Y Ihara, K Egashira, K Nakano, K Ohtani, M Kubo, J Koga, M Iwai, M Horiuchi, Z Gang, S Yamagishi, K Sunagawa
    posted to no-tag by jyuh on 2008-01-16 02:07:24 as **
  • Oral administration of AST-120 (Kremezin) is a promising therapeutic strategy for advanced glycation end product (AGE)-related disorders.
    Med Hypotheses, Vol. 69, No. 3. (2007), pp. 666-668.
    by S Yamagishi, K Nakamura, T Matsui, H Inoue, M Takeuchi
    posted to no-tag by jyuh on 2008-01-14 12:00:24 as **
  • cDNA cloning and characterization of a secreted luciferase from the luminous Japanese ostracod, Cypridina noctiluca.
    Biosci Biotechnol Biochem, Vol. 68, No. 3. (March 2004), pp. 565-570.
    by Y Nakajima, K Kobayashi, K Yamagishi, T Enomoto, Y Ohmiya
    posted to no-tag by jyuh on 2007-10-31 16:26:39 as **
  • Perfusion-culture-based secreted bioluminescence reporter assay in living cells.
    Anal Biochem, Vol. 354, No. 1. (1 July 2006), pp. 15-21.
    by K Yamagishi, T Enomoto, Y Ohmiya
    posted to no-tag by jyuh on 2007-10-31 16:26:23 as **
  • Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation.
    Diabetologia, Vol. 49, No. 12. (December 2006), pp. 3094-3099.
    by T Yoshida, S Yamagishi, K Nakamura, T Matsui, T Imaizumi, M Takeuchi, H Koga, T Ueno, M Sata
    posted to no-tag by jyuh on 2007-10-23 10:12:47 as **
  • Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation.
    Drugs Exp Clin Res, Vol. 30, No. 4. (2004), pp. 169-175.
    by S Yamagishi, M Takeuchi
    posted to no-tag by jyuh on 2007-10-23 10:09:35 as **
  • Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension.
    Microvasc Res, Vol. 70, No. 3. (November 2005), pp. 137-141.
    by K Nakamura, S Yamagishi, Y Nakamura, K Takenaka, T Matsui, Y Jinnouchi, T Imaizumi
    posted to no-tag by jyuh on 2007-10-23 10:09:10 as **
  • Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoattractant protein-1 expression in mesangial cells through downregulation of receptor for AGEs via peroxisome proliferator-activated receptor-gamma activation.
    J Int Med Res, Vol. 35, No. 4. (g 2007), pp. 482-489.
    by T Matsui, S Yamagishi, S Ueda, K Nakamura, T Imaizumi, M Takeuchi, H Inoue
    posted to no-tag by jyuh on 2007-10-23 10:08:26 as **
  • Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells.
    J Biol Chem, Vol. 277, No. 23. (7 June 2002), pp. 20309-20315.
    by S Yamagishi, Y Inagaki, T Okamoto, S Amano, K Koga, M Takeuchi, Z Makita
    posted to no-tag by jyuh on 2007-10-23 03:20:35 as **
  • The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population.
    Kidney Int, Vol. 69, No. 7. (April 2006), pp. 1264-1271.
    by F Irie, H Iso, T Sairenchi, N Fukasawa, K Yamagishi, S Ikehara, M Kanashiki, Y Saito, H Ota, T Nose
    posted to no-tag by jyuh on 2007-10-02 04:05:32 as **
  • Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
    Diabetes Metab Res Rev (10 August 2007)
    by Kazuo Nakamura, Sho-Ichi I Yamagishi, Hisashi Adachi, Takanori Matsui, Yayoi Kurita-Nakamura, Masayoshi Takeuchi, Hiroyoshi Inoue, Tsutomu Imaizumi
    posted to no-tag by jyuh on 2007-09-14 03:06:16 as **
  • Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease.
    Diabetes Metab Res Rev, Vol. 23, No. 5. (July 2007), pp. 368-371.
    by K Nakamura, S Yamagishi, H Adachi, Y Kurita-Nakamura, T Matsui, T Yoshida, A Sato, T Imaizumi
    posted to no-tag by jyuh on 2007-09-14 03:05:18 as **
  • Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes.
    Mol Med, Vol. 13, No. 3-4. (r 2007), pp. 185-189.
    by K Nakamura, S Yamagishi, H Adachi, Y Kurita-Nakamura, T Matsui, T Yoshida, T Imaizumi
    posted to no-tag by jyuh on 2007-09-14 03:04:32 as **
  • Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells.
    Kidney Int, Vol. 63, No. 2. (February 2003), pp. 464-473.
    by S Yamagishi, Y Inagaki, T Okamoto, S Amano, K Koga, M Takeuchi
    posted to no-tag by jyuh on 2007-07-25 02:13:52 as **
  • AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction.
    Kidney Int, Vol. 66, No. 6. (December 2004), pp. 2137-2147.
    by K Fukami, S Ueda, S Yamagishi, S Kato, Y Inagaki, M Takeuchi, Y Motomiya, R Bucala, S Iida, K Tamaki, T Imaizumi, ME Cooper, S Okuda
    posted to no-tag by jyuh on 2007-07-25 02:11:52 as **
    • ◇温馨提示◇本页的引用地址为： http://www.citeulike.org/user/jyuh/author/Yamagishi

    RIS BibTeX RSS